Valspodar limits human cytomegalovirus infection and dissemination

The impact of cytomegalovirus infection on clinical severity and outcomes in kidney transplant recipients with Pneumocystis jirovecii pneumonia

(2020) Sua Lee et al.   MICROBIOLOGY AND IMMUNOLOGY

Interplay Between Calcium and AMPK Signaling in Human Cytomegalovirus Infection

(2020) Diana M. Dunn et al.   Frontiers in Cellular and Infection Microbiology

CD46 facilitates entry and dissemination of human cytomegalovirus

(2019) Kathryn R. Stein et al.   Nature Communications

Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein

(2018) Beatrice Mercorelli et al.   ANTIVIRAL RESEARCH

Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells

(2018) Amila K. Nanayakkara et al.   Scientific Reports

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade

(2016) Zhaolin Chen et al.   CANCER LETTERS

Convallatoxin-Induced Reduction of Methionine Import Effectively Inhibits Human Cytomegalovirus Infection and Replication

(2016) Tobias Cohen et al.   JOURNAL OF VIROLOGY

Functional screening for anti-CMV biologics identifies a broadly neutralizing epitope of an essential envelope protein

(2016) Thomas J. Gardner et al.   Nature Communications

Development of a high-content screen for the identification of inhibitors directed against the early steps of the cytomegalovirus infectious cycle

(2015) Thomas J. Gardner et al.   ANTIVIRAL RESEARCH

Anti-cytomegalovirus activity of the anthraquinone atanyl blue PRL

(2015) Zohaib Alam et al.   ANTIVIRAL RESEARCH

P-glycoprotein in autoimmune rheumatic diseases

(2015) M. García-Carrasco et al.   AUTOIMMUNITY REVIEWS

The role of ABC transporters in ovarian cancer progression and chemoresistance

(2015) M.P. Ween et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

The c-Jun N-terminal kinase inhibitor SP600125 inhibits human cytomegalovirus replication

(2015) Huiping Zhang et al.   JOURNAL OF MEDICAL VIROLOGY

From Na+/K+-ATPase and Cardiac Glycosides to Cytotoxicity and Cancer Treatment

(2013) Petr Babula et al.   Anti-Cancer Agents in Medicinal Chemistry

Development of a High-Throughput Assay To Measure the Neutralization Capability of Anti-Cytomegalovirus Antibodies

(2013) Thomas J. Gardner et al.   Clinical and Vaccine Immunology

A Cutting-Edge View on the Current State of Antiviral Drug Development

(2013) Erik De Clercq   MEDICINAL RESEARCH REVIEWS

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

(2013) Ulrich M. Zanger et al.   PHARMACOLOGY & THERAPEUTICS

Latency-Associated Degradation of the MRP1 Drug Transporter During Latent Human Cytomegalovirus Infection

(2013) M. P. Weekes et al.   SCIENCE

Antiviral Drug Resistance of Human Cytomegalovirus

(2010) N. S. Lurain et al.   CLINICAL MICROBIOLOGY REVIEWS

Human Cytomegaloviruses Expressing Yellow Fluorescent Fusion Proteins - Characterization and Use in Antiviral Screening

(2010) Sarah Straschewski et al.   PLoS One

Artemisinin-Derived Dimers Have Greatly Improved Anti-Cytomegalovirus Activity Compared to Artemisinin Monomers

(2010) Ravit Arav-Boger et al.   PLoS One

Induction of multidrug resistance proteins in lymphocytes from patients with arthritic disorders

(2008) Angela Gradilone et al.   CLINICAL AND EXPERIMENTAL MEDICINE